Inclusion Criteria:
  -  Men or women of any race or ethnicity aged 18 or older
  -  No symptoms of ALS or fronto-temporal dementia at enrollment
  -  Have a first degree relative who had an ALS-spectrum diagnosis with a confirmed ALS-spectrum gene mutation; or already have had genetic testing and have tested positive for an ALS-spectrum gene mutation.
  -  Willing to undergo genetic testing with option of whether or not to learn results
  -  Willing to travel to Columbia University Irving Medical Center (CUIMC) every 6-24 months for study procedures
  -  Capable of providing informed consent and following study procedures, or has a legally authorized representative who is able to consent for the subject.
Exclusion Criteria:
  -  Known HIV
  -  Known hepatitis B
  -  Known hepatitis C